Asbestos & Mesothelioma Studies

ONCOS-102 Passes Safety Evaluation in Phase I Clinical Trials, Phase II Clinical Trial Recommended

December 12, 2017
Categories: , , , , ,

A new immunotherapy developed by Targovax has recently passed Phase I clinical trials and is set to begin Phase II evaluation of this new treatment that may help those suffering from mesothelioma. ONCOS-102 was used in separate Phase I clinical trials; one in combination with chemotherapy, and one with immunotherapy. Cisplatin and pemetrexed are two…

Legitimate Data and Research is Required for Treatment Approval

December 7, 2017
Categories: , ,

For cancer patients who have little success with traditional chemotherapy and radiation treatments, immunotherapy treatments are becoming known alternatives – working with the body’s own immune system to become stronger and better able to fight cancer cells and other infections. A mesothelioma diagnosis is often grim, with survival rates at approximately one year at diagnosis.…

Pleural Catheter vs. Pleurodesis

December 1, 2017
Categories: , ,

Symptoms for pleural mesothelioma are typically centered on lung function breathing, with shortness of breath (dyspnea), pleural effusion (fluid build-up), and pain in the chest being the primary indicators.  There is no cure for malignant pleural mesothelioma and while scientists and researchers are continually developing new treatments and therapies, in the meantime, advancements in palliative…

Smoking Plus Asbestos Exposure – A Deadly Combination

November 21, 2017
Categories: ,

In 2004, the American Thoracic Society called asbestos “the largest cause of occupational cancer in the United States and a significant cause of disease and disability from nonmalignant disease.” Asbestos is a known carcinogen. It has been found to be the cause of many different cancers in those who were exposed to the popular building…

Autophagy Inhibitors Potentially Make Chemotherapy More Effective in Mesothelioma Patients

November 15, 2017
Categories: , ,

Autophagy is a natural and regulated self-degradative process in cells that plays a critical role in balancing sources of energy and removing aggravated proteins, damaged organelles, and pathogens. During autophagy, cells break down and recycle their different parts in order to make new cells. In mesothelioma, autophagy is necessary for mesothelial cell growth. A recent…

November is Lung Cancer Awareness Month

November 2, 2017
Categories:

The National Cancer Institute places lung cancer as the leading cause of death from cancer in the United States. One out of every four cancer deaths is attributable to lung cancer, and in 2016 alone The America Cancer Society an estimated 158,080 people passed away from this disease. Lung cancer begins in the lungs when…

Palliative Care for Mesothelioma Patients

October 24, 2017
Categories: , ,

What is Palliative Care? For serious illnesses, some patients may receive palliative care, or palliative treatment. Palliative care treats the symptoms of the disease, not the disease itself, in an attempt to provide relief and make the patient as comfortable as possible during their illness. Palliative treatment can be provided at the beginning of treatment,…

Misconceptions about Mesothelioma

October 16, 2017
Categories: ,

Mesothelioma is lung cancer One of the most common areas of the body where mesothelioma develops is the lung, and because of this, many misunderstand mesothelioma to be a type of lung cancer. In actuality, mesothelioma is cancer of the mesothelium – found in the lining of the heart, lungs, abdomen, or internal reproductive organs.…

Pleurectomy and Decortication Improve Survival, but May Impact Quality Of Life

October 11, 2017
Categories: , ,

Pleurectomy and Decortication (P/D) is a two-part surgical procedure that removes the pleural lining around the lungs (pleurectomy) and tumors along the surface area of the lung (decortication). To qualify for this surgery, mesothelioma patients must be in overall good health, and in the early stages of the disease. Since mesothelioma is an aggressive cancer…

The Effectiveness of Cisplatin and Pemetrexed in Pericardial Mesothelioma

October 6, 2017
Categories: , ,

Out of all the types of mesothelioma, pericardial mesothelioma is one of the rarest forms, accounting for only 0.002% of all known diagnosed mesothelioma cases. Mesothelioma is caused by asbestos exposure, and despite this knowledge and years of research, scientists and researchers still do not have a clear answer as to how the asbestos fibers…